CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

In a world where agriculture is confronted with unprecedented challenges—such as climate variability, emerging pathogens, and soil degradation, in addition ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

A groundbreaking CRISPR tool could reverse the global antibiotic resistance crisis. Could this be the end of superbugs?

The 2026 Priestley Medalist and Nobel laureate struggled with finding her way through school before achieving the greatest feats in science ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

The global pharmaceutical market, now valued at roughly $1.7 trillion, continues to expand. With nearly $4.9 trillion spent annually on healthcare in the U.S. alone—half of the worldwide ...

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high cholesterol.

Last year’s federal agency layoffs, grant discontinuations, and university funding cuts led to numerous warnings of the disastrous impact on U.S. science research. Gretchen Goldman, PhD, from the ...